Searched for
CHINA PHARMACEUTICAL REGULATIONS
Pharma body renews push for data protectionLeading pharmaceutical companies seek Regulatory Data Protection to boost research investments. Public health groups and local makers oppos...- Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...
- India’s development ladder after AI: What comes next?India’s future prosperity may increasingly depend on empowering its smaller economic units to become more productive using AI.
- India, Russia prevented global economy from collapsing: IMEMO chiefRussia and India have forged a new global economic model, preventing global collapse and aiding the Global South with affordable resources....
- Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
- India's biggest trade bet comes with six red flagsIndia may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...
- India’s rising export champion faces a critical credibility testIndia's seafood exports are soaring, reaching record highs and aiming for $30 billion within five years. Despite overcoming US tariffs and ...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- 'India more diversified:' Sebi chief Tuhin Kanta Pandey comments on Taiwan's market ascentSEBI chief Tuhin Kanta Pandey emphasized India remains a diversified market despite Taiwan overtaking its market value. Driven by TSMC and ...
- From axles to rare earth: India draws up list of 100 products it still can't make enough ofIndia is set to boost its manufacturing sector by identifying around 100 products for domestic production. This initiative aims to reduce r...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Indo-Pacific trade pact losing relevance under Trump’s aggressive strategy: GTRIThe Indo-Pacific Economic Framework for Prosperity, widely known as IPEF, faces significant hurdles. Recent analyses indicate that the foun...
- Govt has eased FDI norms for foreign cos having small Chinese/Hong Kong stake: An explainerIndia has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...
- China halts sale of Sun Pharma drug used to treat dementiaChina's medicine regulator has halted the import, sale, and use of Sun Pharmaceutical Industries' dementia drug, rivastigmine hydrogen tart...
- India looking beyond US for pharma exports amid tariff tensionsIndia aims to increase medicine exports to Africa, Latin America, and Southeast Asia. This strategy reduces reliance on the United States d...
- Prices of medicines to go up a tad; companies seek 20% jumpPrices of essential medicines including painkillers, antiinfectives, cardiac and antibiotics could go up marginally from April, with the go...
- Drug makers get nod to raise one-time price increase on heparin injectionsThe NPPA has allowed for upward revision of heparin injection 1000IU/ ml and heparin injection 5000IU/ ml under para 19 of DPCO 2013 by 50%...
- India calls for 'clear roadmap' from China to ramp up Indian pharmaceutical exportsBesides pharmaceuticals, India has been asking China to open up its IT market as well to ensure steady increase of Indian exports.
- India plans to lessen its drug reliance on ChinaCurrently, India gets 80% of its medicine supplies from China. Following Doval’s alert, govt had formed a panel to formulate a policy to bo...
- China major supplier of APIs to Indian pharma companiesIndian firms imported APIs and intermediates worth nearly $3 bn in 2010-11 with China alone accounting for $1.88 bn, data showed.
Load More
